Home page -
Our goals in organizing this year's Scientific Sessions are listed below. With your participation, we will accomplish them.
To present recent advances in the diagnosis, treatment, and prevention of cardiovascular disease and stroke for physicians, scientists, nurses, and healthcare professionals.
To present new clinical research advances through the Late Breaking Clinical Trials sessions.
To provide a forum for the exchange of new research by scientists/investigators working in cardiovascular disease and stroke.
To provide an opportunity, in various forums including small groups, for attendees to interact with experts in question-and-answer sessions related to daily practice and public health issues.
To provide, through the Cardiovascular Seminars, How-To Sessions, and Sunday Morning Programs, a review of current patterns in the prevention, diagnosis and treatment of cardiovascular disease and stroke.
To provide attendees, through the Plenary Sessions, an opportunity to learn about state-of-the-art cardiovascular research and how it applies to clinical practice.
Educational programming at Scientific Sessions will provide attendees with the opportunity to:
Identify key areas of cutting edge research in heart failure, atherosclerosis, stroke, cardiovascular genetics and molecular biology, and arrhythmias.
Understand basic processes linking cellular biology and biochemistry with cardiovascular physiology.
Understand how new laboratory techniques may be used to answer fundamental questions about cardiovascular pathophysiology.
Discuss novel concepts regarding the development of atherosclerosis and heart failure.
Understand the promises and pitfalls of gene therapy for cardiovascular disease.
Discuss emerging clinical science and its relation to clinical practice in patients with cardiovascular disease and stroke.
Assimilate the "state of the art" knowledge base in multiple subspecialty areas of clinical cardiology.
Implement new strategies and specific therapies for the treatment of cardiovascular disorders and stroke.
Identify emerging trends in the distribution of cardiovascular disease and stroke and their impact on public health.
Discuss newly identified risk factors for cardiovascular disease and stroke.
Implement more effective strategies for prevention of cardiovascular disease and stroke in clinical practice.
Scientific Sessions 2005 in Dallas, Texas
March 15 Abstract Submission Opens
May 27 Abstract Submission Closes
June 1 Late-Breaking Clinical Trial Application Opens
June 3 Early Career Investigator Award Applications Deadline
June 8 Advance Registration open to members
June 15 Advance Registration open to members & nonmembers
June 30 Late-Breaking Clinical Trial Application Deadline
Sept. 1 Late-Breaking Basic Science Abstract Submissions Open
Sept. 15 Late-Breaking Basic Science Abstract Submissions Deadline
Sept. 30 Must become an AHA/ASA Professional Member by Sept. 30 to receive discount on Advance Registration.
Oct. 14 Advance Registration Closes